Application of nanoparticles to reverse multi-drug resistance in cancer

被引：7

作者：

Yang, Jie ^{[1
]}

Zhang, Haijun ^{[1
]}

Chen, Baoan ^{[1
]}

机构：

[1] Southeast Univ, Sch Med, Zhongda Hosp, Dept Hematol & Oncol, Nanjing 210009, Jiangsu, Peoples R China

来源：

NANOTECHNOLOGY REVIEWS | 2016年 / 5卷 / 05期

关键词：

cancer; multi-drug resistance (MDR); nanoparticles (NPs); MESOPOROUS SILICA NANOPARTICLES; OVERCOME DRUG-RESISTANCE; VINCRISTINE SULFATE DELIVERY; SOLID LIPID NANOPARTICLES; BREAST-CANCER; CO-DELIVERY; MULTIFUNCTIONAL NANOPARTICLES; IN-VITRO; MAGNETIC NANOPARTICLES; HYALURONIC-ACID;

D O I：

10.1515/ntrev-2016-0023

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Multi-drug resistance (MDR) poses a large obstacle to various human malignancies. For a long period, combination of multiple therapeutic agents has been the conventional method used to reverse MDR in cancer. However, it is still not an effective method as rather than cancer its serious side effects causes patient's death. Nanoparticles (NPs) are emerging as a class of therapeutics for cancer, including overcoming MDR. In the present review, we focus on the application of NPs to reverse MDR in cancer. Several kinds of NPs developed for the reversal of MDR are summarized. In addition, investigations in vitro and in vivo are also shown to highlight the advancement in the application of NPs to reverse MDR.

引用

页码：489 / 496

页数：8

共 50 条

[31] Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges
Duan, Chunyan
Yu, Mingjia
Xu, Jiyuan
Li, Bo-Yi
Zhao, Ying
Kankala, Ranjith Kumar
BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
[32] Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer
Halder, Jitu
Pradhan, Deepak
Kar, Biswakanth
Ghosh, Goutam
Rath, Goutam
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2022, 40
[33] Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance
Wu, Jin-Long
He, Xiao-Yan
Liu, Bo-Ya
Gong, Meng-Qing
Zhuo, Ren-Xi
Cheng, Si-Xue
JOURNAL OF MATERIALS CHEMISTRY B, 2017, 5 (24) : 4697 - 4704
[34] Reversing multi-drug resistance by polymeric metformin to enhance antitumor efficacy of chemotherapy
Zhang, Hongyan
Yu, Jiandong
Ma, Lisha
Zhao, Yue
Xu, Shujun
Shi, Jingbin
Qian, Ke
Gu, Mancang
Tan, Hongsheng
Xu, Li
Liu, Yun
Mu, Chaofeng
Xiong, Yang
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 624
[35] ANTINEOPLASTIC MULTI-DRUG CHEMOTHERAPY TO SENSITIZE TUMORS TRIGGERS MULTI-DRUG RESISTANCE AND INHIBITS EFFICIENCY OF MAINTENANCE TREATMENT IN GLIOBLASTOMA CELLS
Doganlar, Oguzhan
Doganlar, Zeynep Banu
Erdogan, Suat
Delen, Emre
EXCLI JOURNAL, 2022, 22 : 35 - 52
[36] Resveratrol-Mediated Reversal of Tumor Multi-Drug Resistance
Hu, Yutong
Li, Chuangang
Li, Hong
Li, Molin
Shu, Xiaohong
CURRENT DRUG METABOLISM, 2014, 15 (07) : 703 - 710
[37] Multi-drug sequential release systems: Construction and application for synergistic tumor treatment
Yang, Boyuan
Liang, Huijuan
Xu, Jiahao
Liu, Yanchi
Ma, Sha
Li, Yuqiu
Wang, Chengxiao
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2025, 670
[38] EGF induces cell motility and multi-drug resistance gene expression in breast cancer cells
Garcia, Ruben
Franklin, Richard A.
McCubrey, James A.
CELL CYCLE, 2006, 5 (23) : 2820 - 2826
[39] The potential of multi-compound nanoparticles to bypass drug resistance in cancer
C. G. Da Silva
Godefridus J. Peters
Ferry Ossendorp
Luis J. Cruz
Cancer Chemotherapy and Pharmacology, 2017, 80 : 881 - 894
[40] Synthesis of bee venom loaded chitosan nanoparticles for anti-MERS-COV and multi-drug resistance bacteria
Elnosary, Mohamed E.
Aboelmagd, Hesham A.
Habaka, Manal A.
Salem, Salem R.
El-Naggar, Mehrez E.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 224 : 871 - 880

← 1 2 3 4 5 →